A detailed history of Northside Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Northside Capital Management, LLC holds 11,175 shares of ABBV stock, worth $1.96 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
11,175
Previous 11,175 -0.0%
Holding current value
$1.96 Million
Previous $1.92 Million 15.14%
% of portfolio
0.35%
Previous 0.33%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 13, 2023

BUY
$138.31 - $165.87 $44,120 - $52,912
319 Added 2.94%
11,175 $0
Q4 2021

Jan 24, 2022

SELL
$107.43 - $135.93 $27,716 - $35,069
-258 Reduced 2.32%
10,856 $1.47 Million
Q1 2021

Apr 27, 2021

SELL
$102.3 - $112.62 $20,357 - $22,411
-199 Reduced 1.76%
11,114 $1.2 Million
Q4 2020

Jan 22, 2021

SELL
$80.49 - $108.67 $122,022 - $164,743
-1,516 Reduced 11.82%
11,313 $1.21 Million
Q2 2020

Jul 15, 2020

BUY
$73.37 - $98.18 $10,491 - $14,039
143 Added 1.13%
12,829 $1.26 Million
Q3 2019

Oct 11, 2019

SELL
$62.98 - $75.72 $77,591 - $93,287
-1,232 Reduced 8.85%
12,686 $961,000
Q2 2019

Jul 16, 2019

BUY
$65.7 - $83.98 $7,227 - $9,237
110 Added 0.8%
13,918 $1.01 Million
Q1 2019

Apr 12, 2019

BUY
$77.14 - $90.79 $20,827 - $24,513
270 Added 1.99%
13,808 $1.11 Million
Q4 2018

Jan 14, 2019

BUY
$77.85 - $96.01 $66,328 - $81,800
852 Added 6.72%
13,538 $1.25 Million
Q3 2018

Oct 11, 2018

SELL
$88.91 - $98.84 $148,479 - $165,062
-1,670 Reduced 11.63%
12,686 $1.2 Million
Q2 2018

Jul 11, 2018

SELL
$89.78 - $106.23 $48,481 - $57,364
-540 Reduced 3.63%
14,356 $1.33 Million
Q1 2018

Apr 13, 2018

BUY
$92.01 - $123.21 $14,261 - $19,097
155 Added 1.05%
14,896 $1.41 Million
Q3 2017

Oct 20, 2017

BUY
$69.85 - $89.22 $1.03 Million - $1.32 Million
14,741
14,741 $1.31 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northside Capital Management, LLC Portfolio

Follow Northside Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northside Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northside Capital Management, LLC with notifications on news.